UiPath PATH has been analyzed by 17 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 2 | 14 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 1 | 1 | 12 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 1 | 1 | 0 | 0 |
Analysts have set 12-month price targets for UiPath, revealing an average target of $17.18, a high estimate of $29.00, and a low estimate of $12.00. A 35.73% drop is evident in the current average compared to the previous average price target of $26.73.
Investigating Analyst Ratings: An Elaborate Study
In examining recent analyst actions, we gain insights into how financial experts perceive UiPath. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Michael Turrin | Wells Fargo | Lowers | Equal-Weight | $14.00 | $15.00 |
Frederick Havemeyer | Macquarie | Lowers | Neutral | $12.00 | $29.00 |
Keith Bachman | BMO Capital | Lowers | Market Perform | $14.00 | $28.00 |
Kingsley Crane | Canaccord Genuity | Lowers | Buy | $19.00 | $30.00 |
Raimo Lenschow | Barclays | Lowers | Equal-Weight | $16.00 | $25.00 |
Mark Murphy | JP Morgan | Lowers | Overweight | $19.00 | $28.00 |
Gil Luria | DA Davidson | Lowers | Neutral | $13.00 | $24.00 |
Keith Weiss | Morgan Stanley | Lowers | Equal-Weight | $15.00 | $25.00 |
Michael Turrin | Wells Fargo | Lowers | Equal-Weight | $15.00 | $25.00 |
Kirk Materne | Evercore ISI Group | Lowers | In-Line | $13.00 | $27.00 |
Siti Panigrahi | Mizuho | Lowers | Neutral | $14.00 | $25.00 |
Terry Tillman | Truist Securities | Lowers | Hold | $14.00 | $32.00 |
Brad Sills | B of A Securities | Lowers | Neutral | $16.00 | $30.00 |
Bryan Bergin | TD Cowen | Lowers | Hold | $17.00 | $28.00 |
Nick Altmann | Scotiabank | Lowers | Sector Perform | $25.00 | $30.00 |
Jason Celino | Keybanc | Announces | Overweight | $27.00 | - |
Matthew Hedberg | RBC Capital | Maintains | Sector Perform | $29.00 | - |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to UiPath. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of UiPath compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of UiPath's stock. This analysis reveals shifts in analysts' expectations over time.
To gain a panoramic view of UiPath's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on UiPath analyst ratings.
All You Need to Know About UiPath
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, the right to access certain software products it hosts (i.e., SaaS) and professional services. It generates a majority of its revenues from the Americas followed by Europe, Middle East, and Africa and Asia-Pacific.
Breaking Down UiPath's Financial Performance
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, UiPath showcased positive performance, achieving a revenue growth rate of 15.72% as of 30 April, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: UiPath's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -8.58%, the company may face hurdles in effective cost management.
Return on Equity (ROE): UiPath's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -1.42%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): UiPath's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.99%, the company may face hurdles in achieving optimal financial performance.
Debt Management: UiPath's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.04.
The Significance of Analyst Ratings Explained
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.